Speech-Language Pathologists in West Bloomfield, MI Accepting Medicare
86 Speech-Language Pathologists found. Showing 81 - 86
 Mrs. Antoinette Bryant, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7012 Lakemont Circle, West Bloomfield, MI 48323 Phone: 248-683-7116 Fax: 248-683-7118 |
Sarah Cheng Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4086 Winterset Ln, West Bloomfield, MI 48323 Phone: 248-515-9354 |
Marla Zerbib, M.A., CCC/SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6625 Daly Rd, West Bloomfield, MI 48322 Phone: 248-737-3430 Fax: 248-737-3433 |
Shannon Joan Nelson, MA, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6625 Daly Rd, West Bloomfield, MI 48322 Phone: 248-909-5407 Fax: 248-737-3433 |
Julie Glazebrook, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6625 Daly Rd, West Bloomfield, MI 48322 Phone: 248-737-3430 Fax: 248-737-3433 |
Amy Eidt, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6010 W Maple Rd, Suite 215, West Bloomfield, MI 48322 Phone: 248-539-2900 |
News Archive
Weather and pollution affect outcomes after heart attack
Pollution and weather influence outcomes after a heart attack, according to research presented at ESC Congress today by Ms Aneta Cislak, research fellow in the Silesian Centre for Heart Diseases, Medical University of Silesia in Zabrze, Poland.
New portable device with hand-held probe could help reduce unnecessary thyroid cancer surgery
A team of experts from around Europe has come together to develop a portable device with a hand-held probe that will dramatically reduce invasive diagnostic and therapeutic procedures in the treatment of thyroid nodules, saving approximately €450 million Euros every year.
State highlights: N.C. Medicaid reform plan unveiled; cutting back Medicaid estate recoveries
A selection of health policy stories from Arizona, Colorado, Connecticut, D.C., Florida, New York, and North Carolina.
Glycotope receives German, Italian regulatory approval for CetuGEX Phase I study for solid cancers
Glycotope GmbH, a leading glycobiology company, has received regulatory approval by German and Italian regulatory authorities for a Phase I study of Glycotope´s next generation antibody CetuGEX™ (GT-MAB 5.2-GEX) for the treatment of various solid cancers.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Podiatrists
Chiropractors
Optometrists
Audiologists